Senior Analyst, Financial Risk Management

Princeton, New Jersey, United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree in Finance, Business, Computer Science, or a related field, with a demonstrated interest or experience in treasury, financial analysis, audit, or corporate accounting. Strong analytical, technical, communication, problem-solving, and organizational skills are essential, along with an external focus, strategic perspective, attention to detail, and the ability to quickly learn new concepts and collaborate effectively with internal and external stakeholders.

Responsibilities

This role supports foreign exchange hedging programs, manages the company's cash portfolio, and participates in pension and benefits plan activities. Key responsibilities include aggregating and validating balance sheet FX exposure, executing hedges, analyzing variance drivers, managing the investment portfolio, ensuring daily cash and liquidity, monitoring retirement plan investments, assisting with plan audits and SOX controls, and supporting financial risk management colleagues with various hedging and issuance activities.

Skills

Financial Risk Management

Foreign Exchange Hedging

Investment Management

Cash Management

Liquidity Management

Retirement Plan Administration

SOX Compliance

ERP Systems

360T

Data Analysis

Cross-functional Collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free